Tag: Drug pricing
Canada Drug Agency shouldn’t be determining cost-effectiveness of drugs
Jeremy Bray, a 30-year-old Manitoban with Type 2 spinal muscular atrophy (SMA), is an awful case study of how health care bureaucracy can jeopardize the health of Canadians.